<h4>Objective</h4>To explore the clinical characteristics of recurrent pediatric anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated autoimmune encephalitis and to enhance understanding of this disease.<h4>Methods</h4>We conducted a retrospective analysis of the clinical data of a pediatric patient with recurrent anti-GAD65 antibody-associated encephalitis.<h4>Results</h4>The patient was a 7-year-old boy who presented with slurred speech and epileptic seizures in June 2024. Here, GAD2 is linked to autoimmune encephalitis.